Keyword: New York

It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral.

Sen. Sanders said it's time for Congress to force CEOs to testify on the opioid crisis as lawyers negotiate a potential settlement.

A new front has opened in the fight to make the pharma industry responsible for disposing of unused meds, this time in New York.

The vacant Novartis manufacturing facility in Suffern, New York, sold for $18 million to a buyer who then resold it to a developer for $30 million.

Bristol-Myers Squibb and Pfizer are riding a hot streak defending against Eliquis liability lawsuits, prevailing in several dozen recent cases.

Even after Mylan's board won re-election last week, still-unappeased shareholders aren’t giving up on their demands for a housecleaning.

Drug-delivery specialist Aptar Pharma is beefing up capacity at a New York plant to bring supplies of a key product closer to U.S. customers.

Pfizer and Bristol-Myers face three new lawsuits in New York claiming their big-selling anticoagulant Eliquis ended up hurting patients.

Nevada’s Senate has passed a tough new bill that would publicly spotlight insulin makers' price hikes and profits.

Pfizer thought it had escaped the prospect of paying royalties on its lung cancer drug Xalkori, but an appeals court has resurrected NYU's legal claims.